· treatment of lichen planus is challenging, and therapeutic options have remained stagnant. In mice, saracatinib turned off a protein that allowed synapses to start working again. — a new treatment is showing promise for people with high-risk smoldering multiple myeloma (smm). Explore comprehensive guides on hundreds of common and rare diseases and conditions from the experts at mayo clinic. To date, researchers have not developed any disease-specific medications for lichen planus. · a medicine initially developed as a possible cancer treatment — saracatinib — is now being tested in alzheimers disease. This precancerous condition can progress to active multiple myeloma, a type of blood cancer. · treatment for this type of anemia focuses on the disease thats causing it. · rochester, minn. If symptoms become severe, treatment might include getting blood, called a transfusion, or shots of a hormone called erythropoietin. High-risk smm carries a higher likelihood of progression. While there is no cure, various treatments can help manage symptoms.
